Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
MiroBio is Harnessing the natural control mechanisms of the immune system.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Averna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Forte Biosciences is a biotechnology company that focuses on dermatology.
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
vVardis develops oral care and dental treatment products using biomimetic peptide technology to address tooth decay and enamel repair.
Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals.
OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 17 different industry categories.
Among tracked funding rounds, Apogee Therapeutics received $1.3B in a Post-IPO Debt round. OrbiMed's total known invested capital is $23.6B.
OrbiMed's average investment size is $104.0M across its portfolio of 289 companies.
Recent OrbiMed portfolio additions include MiroBio, Vigil Neuroscience, Nuvation Bio, Averna Therapeutics, Helus Pharma. These companies were founded in 2020 or later.